CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67NH6

Market Closed - Bid/Ask 08:36:16 29/05/2024 BST After market 20:34:39
104.4 EUR -1.08% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO. 104.9 +0.51%
Current month-1.37%
1 month-0.99%
Date Price Change
29/05/24 104.4 -1.08%
28/05/24 105.5 -0.81%
27/05/24 106.4 -0.52%
24/05/24 106.9 +0.07%
23/05/24 106.8 +0.36%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 08:36 am

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67NH
ISINDE000PC67NH6
Date issued 25/03/2024
Strike 140 $
Maturity 18/06/2026 (750 Days)
Parity 1 : 1
Emission price 99.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 107.4
Lowest since issue 103
Spread 0.04
Spread %0.04%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
126.1 USD
Average target price
141.9 USD
Spread / Average Target
+12.52%
Consensus